MPO and interstitial lung disease: These findings are consistent with previous studies demonstrating significantly higher MPO-ANCA titers in patients with ILD in the context of MPA compared to ANCA-positive IPF patients [47] and in patients with MPO-AAV who have poor initial renal function and worse renal outcomes [48].